The obesity drug tirzepatide, or Zepbound, may help patients suffering from sleep apnea, according to a study by Eli Lilly. Gina Kolata, a medical reporter for the New York Times, joins CBS News with more details on the medical observation.
Obesity rate in U.S. adults no longer growing, new CDC data suggests
September 24, 2024
